Page last updated: 2024-10-22

4-(acetylamino)benzeneacetic acid and Extravascular Hemolysis

4-(acetylamino)benzeneacetic acid has been researched along with Extravascular Hemolysis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"The photobiological properties of 4-acetylaminophenylacetic acid (Actarit, ACT, MS-932, CAS 18699-02-0) were studied using in vitro phototoxicity assays: photohemolysis, photoperoxidation of linoleic acid and Candida sp phototoxicity test."3.74Photosensitizing properties of Actarit, an antirheumatic drug. ( Canudas, N; Castelli, C; Figueroa, L; Fuentes, JM; Guedez, A; Taddei, A; Villamizar, JE; Zamora, D, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canudas, N1
Figueroa, L1
Zamora, D1
Villamizar, JE1
Guedez, A1
Fuentes, JM1
Castelli, C1
Taddei, A1

Other Studies

1 other study available for 4-(acetylamino)benzeneacetic acid and Extravascular Hemolysis

ArticleYear
Photosensitizing properties of Actarit, an antirheumatic drug.
    Arzneimittel-Forschung, 2008, Volume: 58, Issue:4

    Topics: Antirheumatic Agents; Candida; Dose-Response Relationship, Drug; Erythrocytes; Free Radicals; Hemoly

2008